{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T13:15:29Z","timestamp":1792156529652,"version":"4.4.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["09150171910029"],"award-info":[{"award-number":["09150171910029"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"Horizon Europe","doi-asserted-by":"publisher","award":["965286"],"award-info":[{"award-number":["965286"]}],"id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002996","name":"Hartstichting","doi-asserted-by":"publisher","award":["CVON2014-09"],"award-info":[{"award-number":["CVON2014-09"]}],"id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Med"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.medj.2025.100896","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T22:27:50Z","timestamp":1761949670000},"page":"100896","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Optimizing atrial fibrillation management using a novel patient-level computational model"],"prefix":"10.1016","volume":"7","author":[{"given":"Minsi","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"Barrios-Espinosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiel","family":"Rienstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry J.G.M.","family":"Crijns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Schotten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1418-108X","authenticated-orcid":false,"given":"Jordi","family":"Heijman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medj.2025.100896_bib1","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.medj.2025.100896_bib2","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study","volume":"76","author":"Roth","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.medj.2025.100896_bib3","article-title":"Epidemiology and Management of Atrial Fibrillation and Stroke: Review of Data from Four European Countries","volume":"2017","author":"Ceornodolea","year":"2017","journal-title":"Stroke Res. Treat."},{"key":"10.1016\/j.medj.2025.100896_bib4","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1161\/CIRCULATIONAHA.117.028981","article-title":"Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community Cohorts: Results From the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk Assessment in Europe)","volume":"136","author":"Magnussen","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.medj.2025.100896_bib5","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ijcard.2017.06.033","article-title":"The interplay between atrial fibrillation and heart failure on long-term mortality and length of stay: Insights from the, United Kingdom ACALM registry","volume":"252","author":"Ziff","year":"2018","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.medj.2025.100896_bib6","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJMoa2019422","article-title":"Early Rhythm-Control Therapy in Patients with Atrial Fibrillation","volume":"383","author":"Kirchhof","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.medj.2025.100896_bib7","article-title":"Clinical utility of rhythm control by electrical cardioversion to assess the association between self-reported symptoms and rhythm status in patients with persistent atrial fibrillation","volume":"36","author":"Hermans","year":"2021","journal-title":"Int. J. Cardiol. Heart Vasc."},{"key":"10.1016\/j.medj.2025.100896_bib8","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.hrthm.2018.08.012","article-title":"Identification of paroxysmal atrial fibrillation subtypes in over 13,000 individuals","volume":"16","author":"Wineinger","year":"2019","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.medj.2025.100896_bib9","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/S0140-6736(21)01698-6","article-title":"Implantable loop recorder detection of atrial fibrillation to prevent stroke (The LOOP Study): a randomised controlled trial","volume":"398","author":"Svendsen","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.medj.2025.100896_bib10","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0140-6736(21)01637-8","article-title":"Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmasked, randomised controlled trial","volume":"398","author":"Svennberg","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.medj.2025.100896_bib11","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1093\/cvr\/cvab138","article-title":"Computational models of atrial fibrillation: achievements, challenges, and perspectives for improving clinical care","volume":"117","author":"Heijman","year":"2021","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.medj.2025.100896_bib12","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1152\/physrev.00017.2023","article-title":"Computational modeling of cardiac electrophysiology and arrhythmogenesis: toward clinical translation","volume":"104","author":"Trayanova","year":"2024","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.medj.2025.100896_bib13","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1093\/europace\/euv083","article-title":"Cost-effectiveness of mass screening for untreated atrial fibrillation using intermittent ECG recording","volume":"17","author":"Aronsson","year":"2015","journal-title":"Europace"},{"key":"10.1016\/j.medj.2025.100896_bib14","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/eurheartj\/ehac547","article-title":"Cost-effectiveness of population screening for atrial fibrillation: the STROKESTOP study","volume":"44","author":"Lyth","year":"2023","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.medj.2025.100896_bib15","first-page":"331","article-title":"Prevalence of atrial fibrillation in the Portuguese population aged 40 and over: the FAMA study","volume":"29","author":"Bonhorst","year":"2010","journal-title":"Rev. Port. Cardiol."},{"key":"10.1016\/j.medj.2025.100896_bib16","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1445-5994.1989.tb00271.x","article-title":"Atrial fibrillation and mortality in an elderly population","volume":"19","author":"Lake","year":"1989","journal-title":"Aust. N. Z. J. Med."},{"key":"10.1016\/j.medj.2025.100896_bib17","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke: the Framingham Study","volume":"22","author":"Wolf","year":"1991","journal-title":"Stroke"},{"key":"10.1016\/j.medj.2025.100896_bib18","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.amjcard.2009.07.022","article-title":"Increasing prevalence of atrial fibrillation and flutter in the United States","volume":"104","author":"Naccarelli","year":"2009","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.medj.2025.100896_bib19","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","article-title":"Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study","volume":"285","author":"Go","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.medj.2025.100896_bib20","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1161\/CIRCULATIONAHA.105.595140","article-title":"Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence","volume":"114","author":"Miyasaka","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.medj.2025.100896_bib21","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ahj.2008.03.010","article-title":"Chronic atrial fibrillation: Incidence, prevalence, and prediction of stroke using the Congestive heart failure, Hypertension, Age >75, Diabetes mellitus, and prior Stroke or transient ischemic attack (CHADS2) risk stratification scheme","volume":"156","author":"Rietbrock","year":"2008","journal-title":"Am. Heart J."},{"key":"10.1016\/j.medj.2025.100896_bib22","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1093\/eurheartj\/ehi825","article-title":"Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study","volume":"27","author":"Heeringa","year":"2006","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.medj.2025.100896_bib23","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1136\/heart.86.3.284","article-title":"Trends in the prevalence and management of atrial fibrillation in general practice in England and Wales, 1994-1998: analysis of data from the general practice research database","volume":"86","author":"Majeed","year":"2001","journal-title":"Heart"},{"key":"10.1016\/j.medj.2025.100896_bib24","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1136\/hrt.2006.107573","article-title":"A national survey of the prevalence, incidence, primary care burden and treatment of atrial fibrillation in Scotland","volume":"93","author":"Murphy","year":"2007","journal-title":"Heart"},{"key":"10.1016\/j.medj.2025.100896_bib25","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1161\/CIRCOUTCOMES.111.962688","article-title":"Incidence and prevalence of atrial fibrillation and associated mortality among Medicare beneficiaries, 1993-2007","volume":"5","author":"Piccini","year":"2012","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"10.1016\/j.medj.2025.100896_bib26","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","article-title":"Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study","volume":"129","author":"Chugh","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.medj.2025.100896_bib27","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1093\/europace\/eus333","article-title":"Incidence and prevalence of atrial fibrillation: an analysis based on 8.3 million patients","volume":"15","author":"Wilke","year":"2013","journal-title":"Europace"},{"key":"10.1016\/j.medj.2025.100896_bib28","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/europace\/euac237","article-title":"Global burden of atrial fibrillation\/atrial flutter and its attributable risk factors from 1990 to 2019","volume":"25","author":"Dong","year":"2023","journal-title":"Europace"},{"key":"10.1016\/j.medj.2025.100896_bib31","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ahj.2009.05.010","article-title":"Incidence of atrial fibrillation in whites and African-Americans: the Atherosclerosis Risk in Communities (ARIC) study","volume":"158","author":"Alonso","year":"2009","journal-title":"Am. Heart J."},{"key":"10.1016\/j.medj.2025.100896_bib29","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1093\/eurheartj\/ehi505","article-title":"Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation","volume":"26","author":"Nieuwlaat","year":"2005","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.medj.2025.100896_bib30","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.amjmed.2021.01.017","article-title":"Clinical Outcomes in Asymptomatic and Symptomatic Atrial Fibrillation Presentations in GARFIELD-AF: Implications for AF Screening","volume":"134","author":"Gibbs","year":"2021","journal-title":"Am. J. Med."},{"key":"10.1016\/j.medj.2025.100896_bib32","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/europace\/euaa123","article-title":"Temporal patterns and short-term progression of paroxysmal atrial fibrillation: data from RACE V","volume":"22","author":"De With","year":"2020","journal-title":"Europace"},{"key":"10.1016\/j.medj.2025.100896_bib33","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1001\/jamainternmed.2013.1561","article-title":"Discerning the incidence of symptomatic and asymptomatic episodes of atrial fibrillation before and after catheter ablation (DISCERN AF): a prospective, multicenter study","volume":"173","author":"Verma","year":"2013","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.medj.2025.100896_bib34","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1136\/heartjnl-2022-321027","article-title":"Prevalence and determinants of atrial fibrillation progression in paroxysmal atrial fibrillation","volume":"109","author":"Nguyen","year":"2022","journal-title":"Heart"},{"key":"10.1016\/j.medj.2025.100896_bib35","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1253\/circj.71.294","article-title":"Dose-response effect of flecainide in patients with symptomatic paroxysmal atrial fibrillation and\/or flutter monitored with trans-telephonic electrocardiography: a multicenter, placebo-controlled, double-blind trial","volume":"71","author":"Atarashi","year":"2007","journal-title":"Circ. J."},{"key":"10.1016\/j.medj.2025.100896_bib36","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1056\/NEJMoa1900353","article-title":"Early or Delayed Cardioversion in Recent-Onset Atrial Fibrillation","volume":"380","author":"Pluymaekers","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.medj.2025.100896_bib37","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0735-1097(10)80090-7","article-title":"Flecainide acetate treatment of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation: dose-response studies. The Flecainide Supraventricular Tachycardia Study Group","volume":"17","author":"Pritchett","year":"1991","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.medj.2025.100896_bib38","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ccep.2020.10.011","article-title":"Risk Factors for Atrial Fibrillation Progression","volume":"13","author":"Heijman","year":"2021","journal-title":"Card. Electrophysiol. Clin."},{"key":"10.1016\/j.medj.2025.100896_bib39","series-title":"Life Tables","year":"2019"},{"key":"10.1016\/j.medj.2025.100896_bib40","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12877-019-1050-1","article-title":"Temporal trends in incidence, recurrence and prevalence of stroke in an era of ageing populations, a longitudinal study of the total Swedish population","volume":"19","author":"Modig","year":"2019","journal-title":"BMC Geriatr."},{"key":"10.1016\/j.medj.2025.100896_bib44","series-title":"Statistics Netherlands","year":"2019"},{"key":"10.1016\/j.medj.2025.100896_bib45","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1161\/STROKEAHA.112.677724","article-title":"Remarkable decline in ischemic stroke mortality is not matched by changes in incidence","volume":"44","author":"Vaartjes","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.medj.2025.100896_bib46","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1111\/j.1468-1331.2008.02309.x","article-title":"Nationwide incidence of first stroke and TIA in the Netherlands","volume":"15","author":"Vaartjes","year":"2008","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.medj.2025.100896_bib41","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1093\/eurheartj\/ehs469","article-title":"All-cause mortality in 272,186 patients hospitalized with incident atrial fibrillation 1995-2008: a Swedish nationwide long-term case-control study","volume":"34","author":"Andersson","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.medj.2025.100896_bib42","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa1105575","article-title":"Subclinical atrial fibrillation and the risk of stroke","volume":"366","author":"Healey","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.medj.2025.100896_bib43","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1093\/eurheartj\/ehx042","article-title":"Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT","volume":"38","author":"Van Gelder","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.medj.2025.100896_bib47","article-title":"A Stochastic Individual-Based Model of the Progression of Atrial Fibrillation in Individuals and Populations","volume":"11","author":"Chang","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.medj.2025.100896_bib48","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.020330","article-title":"Comparative Clinical Effectiveness of Population-Based Atrial Fibrillation Screening Using Contemporary Modalities: A Decision-Analytic Model","volume":"10","author":"Khurshid","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.medj.2025.100896_bib49","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1136\/heartjnl-2022-321346","article-title":"Mobile health adherence for the detection of recurrent recent-onset atrial fibrillation","volume":"109","author":"van der Velden","year":"2022","journal-title":"Heart"},{"key":"10.1016\/j.medj.2025.100896_bib50","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1161\/CIRCULATIONAHA.119.044407","article-title":"Comprehensive Evaluation of Rhythm Monitoring Strategies in Screening for Atrial Fibrillation: Insights From Patients at Risk Monitored Long Term With an Implantable Loop Recorder","volume":"141","author":"Diederichsen","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.medj.2025.100896_bib51","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/CIRCULATIONAHA.121.057014","article-title":"Screening for Atrial Fibrillation in Older Adults at Primary Care Visits: VITAL-AF Randomized Controlled Trial","volume":"145","author":"Lubitz","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.medj.2025.100896_bib52","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/ehjdh\/ztad054","article-title":"Smartphone-based atrial fibrillation screening in the general population: feasibility and impact on medical treatment","volume":"4","author":"Gruwez","year":"2023","journal-title":"Eur. Heart J. Digit. Health"},{"key":"10.1016\/j.medj.2025.100896_bib53","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1161\/CIRCULATIONAHA.123.067512","article-title":"Direct Oral Anticoagulants for Stroke Prevention in Patients with Device-Detected Atrial Fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 and ARTESiA Trials","volume":"149","author":"McIntyre","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.medj.2025.100896_bib54","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1161\/01.CIR.92.7.1954","article-title":"Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats","volume":"92","author":"Wijffels","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.medj.2025.100896_bib55","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation","volume":"146","author":"Hart","year":"2007","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.medj.2025.100896_bib56","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"}],"container-title":["Med"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266663402500323X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266663402500323X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T08:59:27Z","timestamp":1778921967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266663402500323X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S266663402500323X"],"URL":"https:\/\/doi.org\/10.1016\/j.medj.2025.100896","relation":{},"ISSN":["2666-6340"],"issn-type":[{"value":"2666-6340","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimizing atrial fibrillation management using a novel patient-level computational model","name":"articletitle","label":"Article Title"},{"value":"Med","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medj.2025.100896","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100896"}}